Literature DB >> 16696104

Development of a rapid DNA screening procedure for the Factor V Leiden mutation.

G A Scobie1, S T Ho, G Dolan, N A Kalsheker.   

Abstract

Aim-To develop a rapid, simple and highly specific DNA screening procedure based on the amplification refractory mutation system (ARMS) to detect the Leiden mutation in whole blood.Methods-ARMS PCR amplification primers with additional mismatches at either -2 or -3, which greatly improves specificity, were constructed to detect the normal Factor V gene and the Leiden mutation in whole blood samples from patients with abnormal clotting results.Results-Construction of ARMS primers with either an additional mismatch at -2 or -3 at the 3' end of the primer could be used to detect the Leiden mutation in 0.5 mu1 whole blood in under three hours. Primers destabilised at position -3 could be used at a lower annealing temperature, which gave greater sensitivity and are now routinely used. A control set of primers was included in the same reaction to act as a positive control.Conclusions-This rapid and specific assay for the factor V Leiden mutation is a useful addition to the investigation of patients with or at risk from thrombovascular disease.

Entities:  

Year:  1996        PMID: 16696104      PMCID: PMC408088          DOI: 10.1136/mp.49.6.m361

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  10 in total

1.  Development of resistance to activated protein C during pregnancy.

Authors:  A M Cumming; R C Tait; S Fildes; A Yoong; S Keeney; C R Hay
Journal:  Br J Haematol       Date:  1995-07       Impact factor: 6.998

2.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

3.  Identification of the five most common cystic fibrosis mutations in single cells using a rapid and specific differential amplification system.

Authors:  G Scobie; B Woodroffe; S Fishel; N Kalsheker
Journal:  Mol Hum Reprod       Date:  1996-03       Impact factor: 4.025

4.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

5.  Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Authors:  J P Vandenbroucke; T Koster; E Briët; P H Reitsma; R M Bertina; F R Rosendaal
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

6.  Phenotyping and genotyping of coagulation factor V Leiden.

Authors:  H Engel; L Zwang; H H van Vliet; J J Michiels; J Stibbe; J Lindemans
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.

Authors:  R M Ferrie; M J Schwarz; N H Robertson; S Vaudin; M Super; G Malone; S Little
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

9.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

10.  Resistance to activated protein C in healthy women taking oral contraceptives.

Authors:  O Olivieri; S Friso; F Manzato; A Guella; F Bernardi; B Lunghi; D Girelli; M Azzini; G Brocco; C Russo
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

  10 in total
  3 in total

1.  Evolving methods for single nucleotide polymorphism detection: Factor V Leiden mutation detection.

Authors:  Herin Oh; Cassandra L Smith
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients.

Authors:  M Beránek; V Koblížek; P Dulíček; J Hegerová; V Palička
Journal:  Physiol Res       Date:  2022-05-26       Impact factor: 2.139

3.  A novel RFLP-ARMS TaqMan PCR-based method for detecting the BRAF V600E mutation in melanoma.

Authors:  Yunqing Zhang; Shoufang Qu; Jinyin Zhao; Ting Yu; Liping Guo; Songchao Yin; Xiaoxu Hu; Weijun Chen; Wei Lai; Jie Huang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.